GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vitasora Health VHL.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.01

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$4.3m

FY2017FY2026

Net income

−A$10.6m

FY2017FY2026

Free cash flow

−A$10.0m

FY2017FY2026

Shareholders' equity

A$16.1m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueA$4.3mA$3.7mA$456,914A$70,533A$253,688A$270,074A$2.2mA$1.0mA$861,455A$825,603
Research and developmentA$383,638A$241,397A$137,132A$377,725A$1.5mA$1.4mA$2.0mA$4.2mA$1.5mA$1.1m
Operating income−A$11.2m−A$10.1m−A$7.6m−A$6.4m−A$7.1m−A$12.2m−A$9.5m−A$9.5m−A$4.1m−A$3.4m
Net income−A$10.6m−A$10.1m−A$7.1m−A$5.8m−A$6.6m−A$11.0m−A$7.3m−A$8.5m−A$3.2m−A$2.5m
Diluted earnings per share-0.01-0.01-0.01-0.01-0.01-0.02-0.01-0.02-0.01-0.01

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsA$18.8mA$18.4mA$6.2mA$3.2mA$4.2mA$9.1mA$4.6mA$1.0mA$2.7mA$2.6m
Cash and short-term investmentsA$3.1mA$419,370A$791,360A$146,162A$1.2mA$8.0mA$3.6mA$319,041A$2.4mA$1.6m
Total liabilitiesA$2.7mA$3.7mA$3.6mA$2.4mA$1.2mA$1.5mA$2.1mA$2.6mA$1.0mA$843,655
Debt——A$1.3mA$149,130A$70,664A$142,470A$892,884A$806,442——
Shareholders' equityA$16.1mA$14.7mA$2.6mA$826,890A$3.0mA$7.6mA$2.5m−A$1.6mA$1.7mA$1.8m
Shares outstanding1,944m1,858m1,213m906m780m723m676m552m476m433m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−A$10.0m−A$9.2m−A$6.6m−A$4.5m−A$8.5m−A$7.3m−A$4.7m−A$6.4m−A$2.1m−A$2.9m
Capital spending−A$4——−A$21,801−A$2,265−A$54,252−A$12,863−A$3,179−A$7,902−A$582
Free cash flow−A$10.0m−A$9.2m−A$6.6m−A$4.5m−A$8.5m−A$7.4m−A$4.7m−A$6.4m−A$2.1m−A$2.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Dec 2024Jun 2024Dec 2023
RevenueA$2.0m−A$671,209A$2.8mA$1.4mA$2.2mA$1.5mA$309,466A$147,448
Operating income−A$5.5mA$167,047−A$5.1m−A$2.2m−A$6.5m−A$3.6m−A$4.0m−A$3.7m
Net income−A$5.5mA$1.1m−A$5.1m−A$2.6m−A$6.5m−A$3.6m−A$3.9m−A$3.2m
Diluted earnings per share-0.000.00-0.00-0.00-0.00-0.00-0.00-0.00
Cash from operations−A$4.0m−A$2.0m−A$5.0m−A$2.0m−A$9.0m−A$4.0m−A$3.0m−A$3.0m
Capital spending−A$4.0m———————
Free cash flow−A$8.0m———————
Total assetsA$18.8mA$18.8mA$19.9mA$19.9mA$18.4mA$7.1mA$6.2mA$6.3m
Cash and short-term investmentsA$3.1mA$3.1mA$3.1mA$3.1mA$394,240A$1.3mA$791,360A$910,058
Debt———A$26,509—A$87,372A$1.3m—
Shareholders' equityA$16.1mA$16.1mA$17.0mA$17.0mA$14.7mA$4.8mA$2.6mA$3.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue292.8%73.7%20.2%
Operating income20.7%-1.7%10.8%
Net income22.5%-0.8%10.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-266.6%-414.6%-604.4%-583.2%
Net margin-259.6%-395.1%-567.8%-526.5%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-1.8-4.4-14.1-4.7-5.4-4.2-12.1-6.3-14.1-7.6
Price to sales4.512.0220.3385.2141.5171.340.851.652.523.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 20-to-1 reverse split · 31 Jul 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.